CRDF

SEC source: 0001104659-17-055891 · a4.xml · nonDerivative · entry 2

Erlander Mark · CIK 0001651537 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,051

F2 · shares: The reporting person is reporting the withholding by Trovagene, Inc. of 12,928 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of the Converted Common Stock to the reporting person on September 2, 2017.

SEC source: 0001104659-17-055891 · a4.xml · nonDerivative · entry 1

Erlander Mark · CIK 0001651537 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,033

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On January 2, 2017, the reporting person was granted 30,001 restricted stock units, all of which vested on September 2, 2017. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 4, 2017.

SEC source: 0001104659-17-055901 · a4.xml · derivative · entry 2

JACOB GARY S · CIK 0001266802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F3 · derivative.exercise_date: On January 2, 2017, the reporting person was granted 9,287 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On January 2, 2017, the reporting person was granted 9,287 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4.

SEC source: 0001104659-17-055901 · a4.xml · nonDerivative · entry 1

JACOB GARY S · CIK 0001266802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,287

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On January 2, 2017, the reporting person was granted 9,287 restricted stock units, all of which vested on September 2, 2017. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 5, 2017.

SEC source: 0001104659-17-055892 · a4.xml · derivative · entry 2

ADAMS THOMAS PHD · CIK 0001234366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 8,806 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F3 · derivative.exercise_date: On January 2, 2017, the reporting person was granted 8,806 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On January 2, 2017, the reporting person was granted 8,806 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4.

SEC source: 0001104659-17-055892 · a4.xml · nonDerivative · entry 1

ADAMS THOMAS PHD · CIK 0001234366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 335,292

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On January 2, 2017, the reporting person was granted 8,806 restricted stock units, all of which vested on September 2, 2017. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 5, 2017.

SEC source: 0001104659-17-055900 · a4.xml · derivative · entry 2

Tennant Stanley · CIK 0001526214 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 8,484 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F3 · derivative.exercise_date: On January 2, 2017, the reporting person was granted 8,484 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On January 2, 2017, the reporting person was granted 8,484 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4.

SEC source: 0001104659-17-055900 · a4.xml · nonDerivative · entry 1

Tennant Stanley · CIK 0001526214 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,878

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On January 2, 2017, the reporting person was granted 8,484 restricted stock units, all of which vested on September 2, 2017. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 5, 2017.

SEC source: 0001104659-17-055893 · a4.xml · derivative · entry 2

Billings Paul · CIK 0001591558 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 6,498 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F3 · derivative.exercise_date: On January 2, 2017, the reporting person was granted 6,498 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On January 2, 2017, the reporting person was granted 6,498 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4.

SEC source: 0001104659-17-055893 · a4.xml · nonDerivative · entry 1

Billings Paul · CIK 0001591558 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,498

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On January 2, 2017, the reporting person was granted 6,498 restricted stock units, all of which vested on September 2, 2017. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 5, 2017.

SEC source: 0001104659-17-055890 · a4.xml · derivative · entry 2

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 12,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F3 · derivative.exercise_date: On January 2, 2017, the reporting person was granted 12,667 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On January 2, 2017, the reporting person was granted 12,667 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4.

SEC source: 0001104659-17-055890 · a4.xml · nonDerivative · entry 1

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On January 2, 2017, the reporting person was granted 12,667 restricted stock units, all of which vested on September 2, 2017. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 5, 2017.

SEC source: 0001104659-17-055889 · a4.xml · derivative · entry 2

Markin Rodney S · CIK 0001393415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 5,943 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F3 · derivative.exercise_date: On January 2, 2017, the reporting person was granted 5,943 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On January 2, 2017, the reporting person was granted 5,943 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4.

SEC source: 0001104659-17-055889 · a4.xml · nonDerivative · entry 1

Markin Rodney S · CIK 0001393415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,943

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On January 2, 2017, the reporting person was granted 5,943 restricted stock units, all of which vested on September 2, 2017. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 5, 2017.

SEC source: 0001104659-17-053434 · a4.xml · derivative · entry 1

Erlander Mark · CIK 0001651537 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,110,000

Underlying: Common Stock · 385,000 shares

Expires 2027-08-22

F1 · derivative.exercise_date: 48,125 vest immediately upon grant and 48,125 vest quarterly for 7 quarters following the date of grant.

SEC source: 0001104659-17-052470 · a4.xml · nonDerivative · entry 1

WELCH WILLIAM J · CIK 0001237522 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 745,392

F1 · price: Mr. Welch was granted a stock award of 745,392 shares of common stock pursuant to the Trovagene, Inc. 2014 Equity Incentive Plan which vested upon date of grant.

SEC source: 0001104659-17-022532 · a4.xml · derivative · entry 1

Erlander Mark · CIK 0001651537 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,001

Underlying: Common Stock · 90,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSU shall vest on January 30, 2018 provided that the reporting person provides continuous service to Trovagene, Inc.

F2 · derivative.expiration_date: The RSU shall vest on January 30, 2018 provided that the reporting person provides continuous service to Trovagene, Inc.

SEC source: 0001104659-17-022530 · a4.xml · derivative · entry 1

WELCH WILLIAM J · CIK 0001237522 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 330,000

Underlying: Common Stock · 130,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest on January 30, 2018 provided that the reporting person provides continuous service to Trovagene, Inc.

F2 · derivative.expiration_date: The RSUs shall vest on January 30, 2018 provided that the reporting person provides continuous service to Trovagene, Inc.

SEC source: 0001104659-17-000632 · a4.xml · derivative · entry 5

Erlander Mark · CIK 0001651537 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,001

Underlying: Common Stock · 75,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F6 · derivative.exercise_date: The RSUs shall vest in equal annual installments over 4 years.

F6 · derivative.expiration_date: The RSUs shall vest in equal annual installments over 4 years.

SEC source: 0001104659-17-000632 · a4.xml · derivative · entry 4

Erlander Mark · CIK 0001651537 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,001

Underlying: Common Stock · 30,001 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F5 · derivative.exercise_date: The RSU shall vest on September 2, 2017 provided that the reporting person provides continuous service to Trovagene, Inc.

F5 · derivative.expiration_date: The RSU shall vest on September 2, 2017 provided that the reporting person provides continuous service to Trovagene, Inc.

SEC source: 0001104659-17-000632 · a4.xml · derivative · entry 3

Erlander Mark · CIK 0001651537 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F4 · derivative.exercise_date: On May 2, 2016, the reporting person was granted 50,000 restricted stock units, all of which vested on January 2, 2017. The common stock into which such vested restricted stock units converted on January 2, 2017 is reported in Table I on this Form 4.

F4 · derivative.expiration_date: On May 2, 2016, the reporting person was granted 50,000 restricted stock units, all of which vested on January 2, 2017. The common stock into which such vested restricted stock units converted on January 2, 2017 is reported in Table I on this Form 4.

SEC source: 0001104659-17-000632 · a4.xml · nonDerivative · entry 2

Erlander Mark · CIK 0001651537 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,032

F2 · shares: The reporting person is reporting the withholding by Trovagene, Inc. of 23,968 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of the Converted Common Stock to the reporting person on January 2, 2017.

SEC source: 0001104659-17-000632 · a4.xml · nonDerivative · entry 1

Erlander Mark · CIK 0001651537 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On May 2, 2016, the reporting person was granted 50,000 restricted stock units, all of which vested on January 2, 2017. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on May 4, 2016.

SEC source: 0001104659-17-000629 · a4.xml · derivative · entry 1

JACOB GARY S · CIK 0001266802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2018.

F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2018.

SEC source: 0001104659-17-000634 · a4.xml · derivative · entry 1

WELCH WILLIAM J · CIK 0001237522 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest in equal annual installments over 4 years.

F2 · derivative.expiration_date: The RSUs shall vest in equal annual installments over 4 years.

SEC source: 0001104659-17-000633 · a4.xml · derivative · entry 1

ADAMS THOMAS PHD · CIK 0001234366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2018.

F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2018.

SEC source: 0001104659-17-000636 · a4.xml · derivative · entry 1

Tennant Stanley · CIK 0001526214 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2018.

F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2018.

SEC source: 0001104659-17-000631 · a4.xml · derivative · entry 1

Billings Paul · CIK 0001591558 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2018.

F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2018.

SEC source: 0001104659-17-000627 · a4.xml · derivative · entry 1

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2018.

F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2018.

SEC source: 0001104659-17-000626 · a4.xml · derivative · entry 1

Markin Rodney S · CIK 0001393415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2018.

F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2018.

SEC source: 0001104659-17-000960 · a4a.xml · derivative · entry 2

JACOB GARY S · CIK 0001266802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,954

Underlying: Common Stock · 9,287 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F3 · derivative.exercise_date: The RSUs shall vest on September 2, 2017.

F3 · derivative.expiration_date: The RSUs shall vest on September 2, 2017.

SEC source: 0001104659-17-000960 · a4a.xml · derivative · entry 1

JACOB GARY S · CIK 0001266802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2018.

F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2018.

SEC source: 0001104659-17-000963 · a4a.xml · derivative · entry 2

ADAMS THOMAS PHD · CIK 0001234366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,473

Underlying: Common Stock · 8,806 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F3 · derivative.exercise_date: The RSUs shall vest on September 2, 2017.

F3 · derivative.expiration_date: The RSUs shall vest on September 2, 2017.

SEC source: 0001104659-17-000963 · a4a.xml · derivative · entry 1

ADAMS THOMAS PHD · CIK 0001234366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2018.

F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2018.

SEC source: 0001104659-17-000966 · a4a.xml · derivative · entry 2

Markin Rodney S · CIK 0001393415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,610

Underlying: Common Stock · 5,943 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F3 · derivative.exercise_date: The RSUs shall vest on September 2, 2017

F3 · derivative.expiration_date: The RSUs shall vest on September 2, 2017

SEC source: 0001104659-17-000966 · a4a.xml · derivative · entry 1

Markin Rodney S · CIK 0001393415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2018.

F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2018.

SEC source: 0001104659-17-000964 · a4a.xml · derivative · entry 2

Billings Paul · CIK 0001591558 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,165

Underlying: Common Stock · 6,498 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F3 · derivative.exercise_date: The RSUs shall vest on September 2, 2017

F3 · derivative.expiration_date: The RSUs shall vest on September 2, 2017

SEC source: 0001104659-17-000964 · a4a.xml · derivative · entry 1

Billings Paul · CIK 0001591558 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2018.

F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2018.

SEC source: 0001104659-17-000962 · a4a.xml · derivative · entry 2

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,334

Underlying: Common Stock · 12,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F3 · derivative.exercise_date: The RSUs shall vest on September 2, 2017.

F3 · derivative.expiration_date: The RSUs shall vest on September 2, 2017.

SEC source: 0001104659-17-000962 · a4a.xml · derivative · entry 1

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2018.

F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2018.

SEC source: 0001104659-17-000961 · a4a.xml · derivative · entry 2

Tennant Stanley · CIK 0001526214 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,151

Underlying: Common Stock · 8,484 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F3 · derivative.exercise_date: The RSUs shall vest on September 2, 2017.

F3 · derivative.expiration_date: The RSUs shall vest on September 2, 2017.

SEC source: 0001104659-17-000961 · a4a.xml · derivative · entry 1

Tennant Stanley · CIK 0001526214 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.

F2 · derivative.exercise_date: The RSUs shall vest on January 2, 2018.

F2 · derivative.expiration_date: The RSUs shall vest on January 2, 2018.

SEC source: 0001104659-16-162837 · a4.xml · nonDerivative · entry 1

Tennant Stanley · CIK 0001526214 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,728

SEC source: 0001104659-16-162787 · a4.xml · nonDerivative · entry 2

WELCH WILLIAM J · CIK 0001237522 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,750

SEC source: 0001104659-16-162787 · a4.xml · nonDerivative · entry 1

WELCH WILLIAM J · CIK 0001237522 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

SEC source: 0001104659-16-162687 · a4.xml · nonDerivative · entry 1

Tennant Stanley · CIK 0001526214 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,728

SEC source: 0001104659-16-162330 · a4.xml · nonDerivative · entry 1

Erlander Mark · CIK 0001651537 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

SEC source: 0001140361-16-086749 · doc1.xml · nonDerivative · entry 1

BRIDGER MANAGEMENT, LLC · CIK 0001166309 · Former 10% Owner

MIGNONE ROBERTO · CIK 0001258394 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,968,115

F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest whole cent. These Shares (as defined below) were sold in multiple transactions at prices ranging from $3.00 to $3.38, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of Shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

F2 · ownership.direct: The shares of Common Stock, $.0001 par value per share (the "Shares"), reported herein as indirectly beneficially owned by the Reporting Persons are held of record by Swiftcurrent Partners, L.P., Swiftcurrent Offshore Master Ltd. and Bridger Healthcare Ltd. Bridger Management LLC is the investment adviser to Swiftcurrent Partners L.P., Swiftcurrent Offshore Master Ltd., and Bridger Healthcare Ltd., and as such, may be deemed to share beneficial ownership of the Shares. Roberto Mignone is the manager of Bridger Management, LLC.

F3 · ownership.direct: Each reporting person and entity named herein disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein and this report shall not be deemed an admission that the reporting person or any entity named herein is the beneficial owner of the securities for purposes of Section 16, or for any other purpose.

F2 · ownership.nature: The shares of Common Stock, $.0001 par value per share (the "Shares"), reported herein as indirectly beneficially owned by the Reporting Persons are held of record by Swiftcurrent Partners, L.P., Swiftcurrent Offshore Master Ltd. and Bridger Healthcare Ltd. Bridger Management LLC is the investment adviser to Swiftcurrent Partners L.P., Swiftcurrent Offshore Master Ltd., and Bridger Healthcare Ltd., and as such, may be deemed to share beneficial ownership of the Shares. Roberto Mignone is the manager of Bridger Management, LLC.

F3 · ownership.nature: Each reporting person and entity named herein disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein and this report shall not be deemed an admission that the reporting person or any entity named herein is the beneficial owner of the securities for purposes of Section 16, or for any other purpose.